0000899243-18-024025.txt : 20180907 0000899243-18-024025.hdr.sgml : 20180907 20180907174756 ACCESSION NUMBER: 0000899243-18-024025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180906 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aivado Manuel CENTRAL INDEX KEY: 0001709603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 181060989 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-06 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001709603 Aivado Manuel C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472 1 1 0 0 President and CEO Stock Option (right to buy) 3.39 2018-09-06 4 A 0 232914 0.00 A 2028-09-05 Common Stock 232914 232914 D This option was granted on September 6, 2018. The shares underlying the option are scheduled to vest in equal monthly installments over four years from September 6, 2018. /s/ Donald Dougherty, attorney-in-fact for Manuel Aivado 2018-09-07